Trending...
- Governor Gavin Newsom signs SB 27, strengthening California's CARE Act and expanding access to behavioral health services
- Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
- RNHA FL Unveils Bold New Leadership Ahead of 2026 Elections
SAN DIEGO - Californer -- TAK1-TAB1 Fusion Human Recombinant
TAK1-TAB1 Fusion Human Recombinant is a high quality protein complex that is artificially created by combining the TAK1 (Transforming growth factor beta-activated kinase 1) and TAB1 (TAK1-binding protein 1) proteins. This fusion protein is commonly used in research settings to study the signaling pathways involved in various cellular processes, such as inflammation, immune response, and cell growth. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
TAK1-TAB1 Fusion Human Recombinant
Catalog number: B2016845
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 10 µg
Molecular Weight or Concentration: 69 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
More on The Californer
Keywords: TAK1: MAP3K7, TGF1a, TGFβ-activated Kinase 1, Mitogen-activated Protein Kinase Kinase Kinase 7, Transforming Growth Factor-β-activated Kinase 1, TGF-β-activated Kinase 1, TAB1: MAP3K7IP1, TAK1-binding Protein 1, TGF-β-activated Kinase 1 and MAP3K7-binding Protein 1, Mitogen-activated Protein Kinase Kinase Kinase 7-interacting Protein 1
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Sakurai H, Nishi A, Sato N, Mizukami J, Miyoshi H, Sugita T. TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways Biochem Biophys Res Commun. 2002 Oct 11;297(5):1277-81.
2: Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction Science. 1996 May 24;272(5265):1179-82.
https://moleculardepot.com/product/tak1-tab1-fusion-human-recombinant/
TAK1-TAB1 Fusion Human Recombinant is a high quality protein complex that is artificially created by combining the TAK1 (Transforming growth factor beta-activated kinase 1) and TAB1 (TAK1-binding protein 1) proteins. This fusion protein is commonly used in research settings to study the signaling pathways involved in various cellular processes, such as inflammation, immune response, and cell growth. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
TAK1-TAB1 Fusion Human Recombinant
Catalog number: B2016845
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 10 µg
Molecular Weight or Concentration: 69 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
More on The Californer
- California steps up to help military, veteran families while the federal government is AWOL
- MyNamePlayer Helps End "Name Shaming"
- California: YIMBYs rejoice! Leaders celebrate Governor Newsom's landmark actions this year to boost housing and affordability
- Long Beach Veterans Day Celebration Returns November 8 in Houghton Park
- Marisela, "La Dama de Hierro," Graces the Cover of RYM Magazine's October Issue
Keywords: TAK1: MAP3K7, TGF1a, TGFβ-activated Kinase 1, Mitogen-activated Protein Kinase Kinase Kinase 7, Transforming Growth Factor-β-activated Kinase 1, TGF-β-activated Kinase 1, TAB1: MAP3K7IP1, TAK1-binding Protein 1, TGF-β-activated Kinase 1 and MAP3K7-binding Protein 1, Mitogen-activated Protein Kinase Kinase Kinase 7-interacting Protein 1
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Sakurai H, Nishi A, Sato N, Mizukami J, Miyoshi H, Sugita T. TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways Biochem Biophys Res Commun. 2002 Oct 11;297(5):1277-81.
2: Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction Science. 1996 May 24;272(5265):1179-82.
https://moleculardepot.com/product/tak1-tab1-fusion-human-recombinant/
Source: Molecular Depot
0 Comments
Latest on The Californer
- UK Website Launches "Toy Time Machine" — Find Your Childhood Christmas Toy in One Click
- Rachel Farris, CPA Named Among Forbes' Top CPAs in America
- California: Crime is down in San Francisco, key law enforcement partnerships yield successful results
- Scott St. Germain, U.S. Army Veteran and Vice President at Genentech, Joins Dream Foundation Board
- New West Symphony: E.T. The Extra-Terrestrial in Concert
- Vesper Public Relations is selected as an official supplier of the LASEC Business Connect Program
- California announces coalition of Governors forming new alliance to protect public health from political interference
- $73.6M Pipeline, $10M Crypto Play & Legal Firepower: Why Investors Are Watching Cycurion (N A S D A Q: CYCU) Like a Hawk
- Grammy award-winning Cuban-Canadian artist Alex Cuba releases his 11th studio album, "Indole"
- Thread Advisory Group Launches to Help Retailers Turn Strategy Into Lasting Results
- QView Medical and Eve Wellness Announce Partnership to Advance Direct-to-Consumer Breast Cancer Screening With FDA-Approved AI
- New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
- Inside the Practice of a Caring Dentist Bringing Personalized Care to La Jolla
- Airbus Defence and Space and Omnitronics Sign MoU to Advance Interoperability in Critical Communications
- City of Long Beach Confirms First Case of Clade I Mpox
- DERMA-CODE™ Introduces the World's First Synergistic Skincare Combining NAD+, PDRN, and Peptides
- Memory and Return – Debut Concert Featuring David Hidalgo and Members of Quetzal
- California protects over 40K acres of agricultural land, supporting rural communities
- Ship Overseas Inc Reports 37% Revenue Growth as EV Shipping to Africa Accelerates
- City of Long Beach Issues Rain Advisory Due to Recent Showers